These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 12228819)

  • 21. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK; Krudsood S; Patel SN; Serghides L; Tangpukdee N; Katz K; Wilairatana P; Liles WC; Looareesuwan S; Kain KC
    Clin Infect Dis; 2009 Sep; 49(6):841-9. PubMed ID: 19673614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine for prevention of malaria in travelers.
    Baird JK; Fryauff DJ; Hoffman SL
    Clin Infect Dis; 2003 Dec; 37(12):1659-67. PubMed ID: 14689349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
    Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R
    J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines.
    Faucher JF; Binder R; Missinou MA; Matsiegui PB; Gruss H; Neubauer R; Lell B; Que JU; Miller GB; Kremsner PG
    Clin Infect Dis; 2002 Nov; 35(10):1147-54. PubMed ID: 12410473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
    Sukwa TY; Mulenga M; Chisdaka N; Roskell NS; Scott TR
    Am J Trop Med Hyg; 1999 Apr; 60(4):521-5. PubMed ID: 10348223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.
    Butcher GA; Sinden RE
    Am J Trop Med Hyg; 2003 Jan; 68(1):111-4. PubMed ID: 12556158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
    Mulenga M; Malunga F; Bennett S; Thuma PE; Shulman C; Fielding K; Alloueche A; Greenwood BM
    Trop Med Int Health; 2006 Nov; 11(11):1643-52. PubMed ID: 17054743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L
    Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.